Last updated: 2026-09-11 17:35:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $63,42, with a market capitalization of $131,57B and a P/E ratio of 14,03. Over the past 52 weeks, its price has ranged from $42,52 to $68,64. This page covers its latest market performance, valuation, price trends and company information.
$131,57B | |
$64,15 | |
$81,44 | |
$16,00 | |
$63,75 | |
2,59M | |
11,24M | |
14,03 | |
$68,64 | |
$42,52 | |
3,91% | |
-- |
Bristol-Myers Squibb Co. (BMY) is currently trading at $63,42 as of 2026-09-11 17:18:55, down 0,52% ($0,33) from the previous close of $63,75
During today's regular trading session, BMY has traded between $16,00 and $81,44, with a trading volume of 2,59M shares. The current price is near the upper end of today's range.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $66,92 to $63,42, representing a decline of 5,23% ($3,50).
The stock traded between $63,29 and $68,24 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 6,91 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 80,0%
BMY is currently trading at $63,42, placing it 80,0% of the way from its 52-week low of $42,52 to its 52-week high of $68,64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.